Abbott Laboratories [NYSE: ABT] loss -1.21% on the last trading session, reaching $105.97 price per share at the time. If compared to the average trading volume of 5.75M shares, ABT reached a trading volume of 5072830 in the most recent trading day, which is why
Abbott Laboratories [NYSE: ABT] jumped around 2.01 points on Friday, while shares priced at $107.28 at the close of the session, up 1.91%. Compared to the average trading volume of 5.88M shares, ABT reached a trading volume of 10520053 in the most recent trading day,
Abbott Laboratories [NYSE: ABT] price surged by 0.29 percent to reach at $0.32. The one-year ABT stock forecast points to a potential upside of 13.82. The average equity rating for ABT stock is currently 1.85, trading closer to a bullish pattern in the stock market.
Abbott Laboratories [NYSE: ABT] traded at a low on Monday, posting a -0.61 loss after which it closed the day’ session at $110.52. The company report on April 2, 2024 at 9:00 AM that Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky
Abbott Laboratories [NYSE: ABT] slipped around -0.07 points on Tuesday, while shares priced at $112.02 at the close of the session, down -0.06%. The company report on April 2, 2024 at 9:00 AM that Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky
Abbott Laboratories [NYSE: ABT] stock went on an upward path that rose over 1.35% on Tuesday, amounting to a one-week price decrease of less than -1.47%. The company report on March 19, 2024 at 8:00 AM that Canadian First – Abbott Advances Chronic Pain Management
Abbott Laboratories [NYSE: ABT] slipped around -3.36 points on Friday, while shares priced at $115.49 at the close of the session, down -2.83%. The company report on March 15, 2024 at 8:30 AM that Diabetes and Heart Disease: How to Manage Your Risk. Abbott If
Abbott Laboratories [NYSE: ABT] slipped around -0.6 points on Wednesday, while shares priced at $120.16 at the close of the session, down -0.50%. The company report on March 11, 2024 at 10:10 AM that Abbott Extends Innovative Health Partnership With Real Madrid and the Real
Abbott Laboratories [NYSE: ABT] gained 0.73% on the last trading session, reaching $119.34 price per share at the time. The company report on March 6, 2024 at 9:00 AM that Real-World Data Show Abbott’s FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People
Abbott Laboratories [NYSE: ABT] traded at a low on Thursday, posting a -1.17 loss after which it closed the day’ session at $118.64. The company report on February 16, 2024 at 10:19 AM that Abbott Declares 401st Consecutive Quarterly Dividend. The board of directors of
© 2024, Powered by Smart TechOne
